biostudies-literatureUnknown66(8)Yarmolinsky JBLRD VACancer Research UKWorld Health OrganizationNCATS NIH HHSNCCDPHP CDC HHSNIA NIH HHSNHLBI NIH HHSWorld Cancer Research FundNIDDK NIH HHSMedical Research CouncilDiabetes UKVA Office of R&DNational Institute for Health Research (NIHR)NCI NIH HHSNIH HHSWHI NIH HHSDiabetologia1481-1500https://www.ebi.ac.uk/biostudies/studies/S-EPMC10317892biostudies-literatureGenetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.PMC10317892U01 CA137088K05 CA154337C68933/A28534K05 CA15271528534KL2 TR00042117/0005587BRC-1215-20011U58 DP002333R21 CA191312R01 DK134575IIG_2019_2009R01 CA076366HHSN268201100001CP30 CA006973I01-BX003362U01 CA122839R01 CA207371R01 CA081488001I01 BX003362MR/M012190/1UM1 DK126194MR/N013794/1HHSN268201100002CHHSN268201100046CU01 CA086308U01 CA167551HHSN268201100003CHHSN261201700006IHHSN268201200008IC18281/A29019S10 OD028685R01 CA114347R01 CA097325R01 CA059045NIHR202411U01 CA164930R01 CA201407U19 CA148107P30 CA015704U24 CA07479429019U01 CA206110HHSN268201100004C29017R03 CA153323HHSN271201100004CU01 AG018033Vujkovic MBerndt SISchoen REKoutros SBurrows KPashayan NChang KMNeal DEWolk AEeles RAHampe JClaessens FRazack AStanford JLMucci LALessel DAl Olama AABrenner HNeuhausen SLRoobol MJTravis RCBlot WJVoight BFUsmani NKibel ASVega AKim JKhaw KTCannon-Albright LBull CJGallinger SWest CMLBouras EJohn EMRiboli EDimopoulou OSchleutker JKogevinas MDe Ruyck KPRACTICAL consortiumAlbanes DLewis SJMoreno VBatra JStevens VLHamilton RJPenney KLHamdy FCCybulski CGill DClements JAVA Million Veteran ProgramSchumacher FRTeixeira MRLu YJPharoah PDPRosenstein BSGrindedal EMNordestgaard BGVincent EEWiklund FCancel-Tassin GGunter MJBenlloch SWang YKote-Jarai ZIngles SADonovan JLTsao PSPellatt AJTsilidis KKNielsen SFThibodeau SNMartin RMKraft PConstantinescu ATangen CMSorensen KDChanock SYarmolinsky JHunter DJPark JYNewcomb LFGiles GGMuir KHaiman CATownsend PAPandha HPai RKMenegaux FGronberg HWeinstein SConti DVJenkins MAMaier CCastelao JEKaneva RfalseGenetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.2023-01-01T00:00:00Z2023 Aug2026-05-29T14:06:16.879Z2025-02-19T03:20:58.714ZS-EPMC103178923717150110.1007/s00125-023-05925-4